A carregar...
Feasibility of Administering High-Dose (131)I-MIBG Therapy to Children with High-Risk Neuroblastoma without Lead-Lined Rooms
BACKGROUND: Although (131)I-metaiodobenzylguanidine therapy ((131)I-MIBG) is increasingly used for children with high-risk neuroblastoma, a paucity of lead-lined rooms limits its wider use. We implemented radiation safety procedures to comply with New York City Department of Health and Mental Hygien...
Na minha lista:
| Publicado no: | Pediatr Blood Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4801722/ https://ncbi.nlm.nih.gov/pubmed/26773712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25892 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|